Range Impact Inc. Files S-1/A for IPO
Ticker: RNGE · Form: S-1/A · Filed: Dec 19, 2024 · CIK: 1438943
| Field | Detail |
|---|---|
| Company | Range Impact, Inc. (RNGE) |
| Form Type | S-1/A |
| Filed Date | Dec 19, 2024 |
| Risk Level | medium |
| Pages | 14 |
| Reading Time | 17 min |
| Key Dollar Amounts | $0.001, $0.198 |
| Sentiment | neutral |
Sentiment: neutral
Topics: ipo, sec-filing, registration
TL;DR
Range Impact (fka Malachite Innovations) filed S-1/A for IPO. Get ready.
AI Summary
Range Impact, Inc. filed an S-1/A amendment on December 19, 2024, for its initial public offering. The company, formerly known as Malachite Innovations, Inc., Vitality Biopharma, Inc., and Stevia First Corp., is incorporated in Nevada and headquartered in Cleveland, Ohio. The filing details its business operations and financial structure as it prepares to go public.
Why It Matters
This S-1/A filing is a crucial step for Range Impact, Inc. as it moves towards becoming a publicly traded company, signaling potential investment opportunities and market impact in its sector.
Risk Assessment
Risk Level: medium — As an S-1/A filing, it represents a company in the process of going public, which inherently carries higher risks than established public companies.
Key Numbers
- 20241219 — Filing Date (Date of the S-1/A amendment filing)
- 333-279203 — SEC File Number (SEC's file number for this registration)
Key Players & Entities
- RANGE IMPACT, INC. (company) — Registrant
- Malachite Innovations, Inc. (company) — Former company name
- Vitality Biopharma, Inc. (company) — Former company name
- Stevia First Corp. (company) — Former company name
- Michael Cavanaugh (person) — Chief Executive Officer
- 200 Park Avenue, Suite 400 Cleveland, Ohio 44122 (address) — Principal executive offices
- 333-279203 (registration_number) — SEC registration number
FAQ
What is the primary business of Range Impact, Inc.?
The filing lists Range Impact, Inc. under the Standard Industrial Classification code for HEAVY CONSTRUCTION OTHER THAN BUILDING CONST - CONTRACTORS [1600].
When was Range Impact, Inc. previously known by other names?
The company was formerly known as Malachite Innovations, Inc. (since 20211012), Vitality Biopharma, Inc. (since 20160721), and Stevia First Corp. (since 20111020).
Who is the Chief Executive Officer of Range Impact, Inc.?
Michael Cavanaugh is listed as the Chief Executive Officer.
What is the principal executive office address?
The principal executive offices are located at 200 Park Avenue, Suite 400, Cleveland, Ohio 44122.
What is the purpose of this S-1/A filing?
This is an Amendment No. 3 to a FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, indicating it's part of the process for an initial public offering.
Filing Stats: 4,324 words · 17 min read · ~14 pages · Grade level 18.4 · Accepted 2024-12-19 12:52:57
Key Financial Figures
- $0.001 — ”) of our Common Stock, par value $0.001 per share (“Common Stock”),
- $0.198 — rted sale price of our Common Stock was $0.198. Investing in our securities involves
Filing Documents
- forms-1a.htm (S-1/A) — 544KB
- ex5-1.htm (EX-5.1) — 19KB
- ex23-1.htm (EX-23.1) — 5KB
- ex107.htm (EX-FILING FEES) — 14KB
- ex5-1_003.jpg (GRAPHIC) — 22KB
- ex5-1_004.jpg (GRAPHIC) — 28KB
- ex23-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-24-050743.txt ( ) — 657KB
RISK FACTORS
RISK FACTORS 10 DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 18
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 20
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 21 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS 22
USE OF PROCEEDS
USE OF PROCEEDS 23 DIVIDEND POLICY 24 DETERMINATION OF OFFERING PRICE 24 SELLING STOCKHOLDERS 25 PLAN OF DISTRIBUTION 27
DESCRIPTION OF SECURITIES TO BE REGISTERED
DESCRIPTION OF SECURITIES TO BE REGISTERED 28 LEGAL MATTERS 31 EXPERTS 31 INCORPORATION OF CERTAIN INFORMATION BY REFERENCE 31 INFORMATION NOT REQUIRED IN PROSPECTUS 32
SIGNATURES
SIGNATURES 36 i ABOUT THIS PROSPECTUS You should rely only on the information we have provided or incorporated by reference in this prospectus, any applicable prospectus supplement and any related free writing prospectus. We have not authorized anyone to provide you with information different from that contained in this prospectus, any applicable prospectus supplement or any related free writing prospectus. No dealer, salesperson or other person is authorized to give any information or to represent anything not contained in this prospectus, any applicable prospectus supplement or any related free writing prospectus. You must not rely on any unauthorized information or representation. This prospectus is an offer to sell only the Shares offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. You should assume that the information in this prospectus, any applicable prospectus supplement or any related free writing prospectus is accurate only as of the date on the front of the document, regardless of the time of delivery of this prospectus or any sale of a security. The Selling Stockholders are offering the Shares only in jurisdictions where such issuances are permitted. The distribution of this prospectus and the issuance of the Shares in certain jurisdictions may be restricted by law. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the issuance of the Shares and the distribution of this prospectus outside the United States. This prospectus does not constitute, and may not be used in connection with, an offer to sell, or a solicitation of an offer to buy, the Shares offered by this prospectus by any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation. This prospectus is part of a registration statement that we filed with the SEC, under which the Selling Stockholders m
Business
Business We are a public company dedicated to improving the health and wellness of people and the planet through a novel and innovative approach to impact investing. We own and operate several complementary operating businesses focused on developing long-term solutions to environmental, social, and health challenges, with a particular focus on acquiring, reclaiming and repurposing mine sites and other undervalued land in economically disadvantaged communities throughout Appalachia. We take an opportunistic approach to impact investing by leveraging our competitive advantages and looking at solving old problems in new ways. We seek to thoughtfully allocate our capital into strategic opportunities that are expected to make a positive impact on the people-planet ecosystem and generate strong investment returns for our shareholders. Impact Investing Strategy Our impact investing strategy aims to improve the health and wellness of people and the planet, while also generating long-term sustainable financial returns for our shareholders. We believe that doing well and doing good are not mutually exclusive, and that an impact investing strategy can balance the environmental, social and economic needs of people and the planet while also generating attractive risk-adjusted financial returns for shareholders. Our impact investing strategy provides an opportunity for our dedicated team to address pressing environmental, social and economic challenges, such as air and water pollution, educational inequality and economic disparity, and climate change, through the development of technology-based solutions. By actively directing investment capital towards businesses that are working to create positive environmental, social and economic outcomes, we believe that our impact investing strategy can contribute to an improved people-planet ecosystem and a healthier and happier way of life. 5 We have a particular interest in providing environmental and social solutions in econ